help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reape, T. J.
Right arrow Articles by Groot, P. H.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reape, T. J.
Right arrow Articles by Groot, P. H.E.
(American Journal of Pathology. 1999;154:365-374.)
© 1999 American Society for Investigative Pathology


Regular Articles

Expression and Cellular Localization of the CC Chemokines PARC and ELC in Human Atherosclerotic Plaques

Theresa J. Reape* , Kim Rayner* , Carol D. Manning{dagger} , Andrew N. Gee* , Mary S. Barnette{dagger} , Kevin G. Burnand{ddagger} and Pieter H.E. Groot*

From the Department of Vascular Biology,* SmithKline Beecham Pharmaceuticals, New Frontiers Science Park North, Coldharbour Road, Harlow, Essex, the United Kingdom, Department of Pulmonary Pharmacology,{dagger} SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, and Department of Surgery,{ddagger} St. Thomas's Hospital, London, the United Kingdom

Local immune responses are thought to play an important role in the development of atherosclerosis. Histological studies have shown that human atherosclerotic lesions contain T lymphocytes throughout all stages of development, many of which are in an activated state. A number of novel CC chemokines have been described recently, which are potent chemoattractants for lymphocytes: PARC (pulmonary and activation-regulated chemokine), ELC (EBI1-ligand chemokine), LARC (liver and activation-regulated chemokine), and SLC (secondary lymphoid-tissue chemokine). Using reverse transcriptase-polymerase chain reaction and in situ hybridization, we have found gene expression for PARC and ELC but not for LARC or SLC in human atherosclerotic plaques. Immunohistochemical staining of serial plaque sections with specific cell markers revealed highly different expression patterns of PARC and ELC. PARC mRNA was restricted to CD68+ macrophages (n = 14 of 18), whereas ELC mRNA was widely expressed by macrophages and intimal smooth muscle cells (SMC) in nearly all of the lesions examined (n = 12 of 14). ELC mRNA was also found to be expressed in the medial SMC wall of highly calcified plaques (n = 4). Very low levels of ELC mRNA expression could also be detected in normal mammary arteries but no mRNA expression for PARC was detected in these vessels (n = 4). In vitro, ELC mRNA was found to be up-regulated in aortic SMC stimulated with tumor necrosis factor-{alpha} and interferon-{gamma} but not in SMC stimulated with serum. Both PARC and ELC mRNA were expressed by monocyte-derived macrophages but not monocytes. The expression patterns of PARC and ELC mRNA in human atherosclerotic lesions suggest a potential role for these two recently described CC chemokines in attracting T lymphocytes into atherosclerotic lesions.





This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Li, T. Syrovets, S. Paskas, Y. Laumonnier, and T. Simmet
Mature Dendritic Cells Express Functional Thrombin Receptors Triggering Chemotaxis and CCL18/Pulmonary and Activation-Regulated Chemokine Induction
J. Immunol., July 15, 2008; 181(2): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Hartung, A. Petrov, N. Haider, S. Fujimoto, F. Blankenberg, A. Fujimoto, R. Virmani, F. D. Kolodgie, H. W. Strauss, and J. Narula
Radiolabeled Monocyte Chemotactic Protein 1 for the Detection of Inflammation in Experimental Atherosclerosis
J. Nucl. Med., November 1, 2007; 48(11): 1816 - 1821.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A.O. Kraaijeveld, S.C.A. de Jager, W.J. de Jager, B.J. Prakken, S.R. McColl, I. Haspels, H. Putter, T.J.C. van Berkel, L. Nagelkerken, J.W. Jukema, et al.
CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms
Circulation, October 23, 2007; 116(17): 1931 - 1941.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Kaur, R. Saunders, P. Berger, S. Siddiqui, L. Woodman, A. Wardlaw, P. Bradding, and C. E. Brightling
Airway Smooth Muscle and Mast Cell-derived CC Chemokine Ligand 19 Mediate Airway Smooth Muscle Migration in Asthma
Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1179 - 1188.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. d. Nadai, A.-S. Charbonnier, C. Chenivesse, S. Senechal, C. Fournier, J. Gilet, H. Vorng, Y. Chang, P. Gosset, B. Wallaert, et al.
Involvement of CCL18 in Allergic Asthma
J. Immunol., May 15, 2006; 176(10): 6286 - 6293.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Rothenbacher, S. Muller-Scholze, C. Herder, W. Koenig, and H. Kolb
Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 194 - 199.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Schutyser, A. Richmond, and J. Van Damme
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes
J. Leukoc. Biol., July 1, 2005; 78(1): 14 - 26.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Weber, A. Schober, and A. Zernecke
Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 1997 - 2008.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. A. Bursill, R. P. Choudhury, Z. Ali, D. R. Greaves, and K. M. Channon
Broad-Spectrum CC-Chemokine Blockade by Gene Transfer Inhibits Macrophage Recruitment and Atherosclerotic Plaque Formation in Apolipoprotein E-Knockout Mice
Circulation, October 19, 2004; 110(16): 2460 - 2466.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. S. Smith, G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko
HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner
J. Leukoc. Biol., July 1, 2004; 76(1): 65 - 76.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Schraufstatter, H. Takamori, L. Sikora, P. Sriramarao, and R. G. DiScipio
Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L494 - L501.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. G. Boot, M. Verhoek, M. de Fost, C. E. M. Hollak, M. Maas, B. Bleijlevens, M. J. van Breemen, M. van Meurs, L. A. Boven, J. D. Laman, et al.
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
Blood, January 1, 2004; 103(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. P. Atamas, I. G. Luzina, J. Choi, N. Tsymbalyuk, N. H. Carbonetti, I. S. Singh, M. Trojanowska, S. A. Jimenez, and B. White
Pulmonary and Activation-Regulated Chemokine Stimulates Collagen Production in Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Struyf, E. Schutyser, M. Gouwy, K. Gijsbers, P. Proost, Y. Benoit, G. Opdenakker, J. Van Damme, and G. Laureys
PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia
Am. J. Pathol., November 1, 2003; 163(5): 2065 - 2075.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Senechal, P. de Nadai, N. Ralainirina, A. Scherpereel, H. Vorng, P. Lassalle, A.-B. Tonnel, A. Tsicopoulos, and B. Wallaert
Effect of Diesel on Chemokines and Chemokine Receptors Involved in Helper T Cell Type 1/Type 2 Recruitment in Patients with Asthma
Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 215 - 221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Gibejova, F. Mrazek, D. Subrtova, V. Sekerova, J. Szotkowska, V. Kolek, R. M. du Bois, and M. Petrek
Expression of Macrophage Inflammatory Protein-3{beta}/CCL19 in Pulmonary Sarcoidosis
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1695 - 1703.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Vulcano, S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, et al.
Unique Regulation of CCL18 Production by Maturing Dendritic Cells
J. Immunol., April 1, 2003; 170(7): 3843 - 3849.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A M A. El-Asrar, S Struyf, S A Al-Kharashi, L Missotten, J Van Damme, and K Geboes
Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis
Br. J. Ophthalmol., October 1, 2002; 86(10): 1175 - 1180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Luther, A. Bidgol, D. C. Hargreaves, A. Schmidt, Y. Xu, J. Paniyadi, M. Matloubian, and J. G. Cyster
Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis
J. Immunol., July 1, 2002; 169(1): 424 - 433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Schutyser, S. Struyf, P. Proost, G. Opdenakker, G. Laureys, B. Verhasselt, L. Peperstraete, I. Van de Putte, A. Saccani, P. Allavena, et al.
Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma
J. Biol. Chem., June 28, 2002; 277(27): 24584 - 24593.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. F. Debes, U. E. Hopken, and A. Hamann
In Vivo Differentiated Cytokine-Producing CD4+ T Cells Express Functional CCR7
J. Immunol., June 1, 2002; 168(11): 5441 - 5447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ludwig, T. Berkhout, K. Moores, P. Groot, and G. Chapman
Fractalkine Is Expressed by Smooth Muscle Cells in Response to IFN-{gamma} and TNF-{alpha} and Is Modulated by Metalloproteinase Activity
J. Immunol., January 15, 2002; 168(2): 604 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Hjelmström
Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines
J. Leukoc. Biol., March 1, 2001; 69(3): 331 - 339.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Lindhout, J. L. M. Vissers, F. C. Hartgers, R. J. F. Huijbens, N. M. Scharenborg, C. G. Figdor, and G. J. Adema
The Dendritic Cell-Specific CC-Chemokine DC-CK1 Is Expressed by Germinal Center Dendritic Cells and Attracts CD38-Negative Mantle Zone B Lymphocytes
J. Immunol., March 1, 2001; 166(5): 3284 - 3289.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Murdoch and A. Finn
Chemokine receptors and their role in inflammation and infectious diseases
Blood, May 15, 2000; 95(10): 3032 - 3043.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. G. Cyster
Chemokines and Cell Migration in Secondary Lymphoid Organs
Science, December 10, 1999; 286(5447): 2098 - 2102.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.